
Drug discovery researchers at Northwestern University have developed a novel orally administered compound specifically targeted to suppress brain cell inflammation and neuron loss associated with Alzheimer's disease. The compound is also rapidly absorbed by the brain and is non-toxic - important considerations for a central nervous system drug that might need to be taken for extended periods. http://www.medicalnewstoday.com/medicalnews.php?newsid=36434
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home